Other

This electronic Clinical Quality Measure (eCQM) reports the percentage of patients aged 45 to 75 years with at least one positive stool-based colorectal cancer screening test (i.e., high-sensitivity guaiac fecal occult blood test, fecal immunochemical test, or Cologuard) during the measurement period (i.e., calendar year) who completed a colonoscopy within 180 days after their index (i.e., first) positive stool-based test result date.

Percentage of surgical patients aged 18 years and older undergoing resection for lung or esophageal cancer who had clinical staging provided prior to surgery

Percentage of surgical patients aged 18 years and older undergoing resection for lung or esophageal cancer who had their performance status recorded within two weeks prior to the surgery date

The risk-adjusted relative resource use by health plan members with asthma during the measurement year.

The risk-adjusted relative resource use by health plan members with specific cardiovascular conditions during the measurement year.

The risk-adjusted relative resource use by health plan members with COPD during the measurement year.

The risk-adjusted relative resource use by health plan members with diabetes (type 1 and type 2) during the measurement year.

This is a hospital based, risk adjusted, case mix adjusted morbidity and mortality aggregate outcome measure of adults 18+ years undergoing colon surgery.

Risk adjusted, case mix adjusted urinary tract infection outcome measure of adults 18+ years after surgical procedure.

The existing NQF-endorsed measure provides a means for determining the risk-adjusted readmission rate for a selected adult target population and can be applied for any desired timeframe. Readmission rate is defined as the percentage of acute inpatient discharges during the measurement period followed by an acute inpatient admission for any diagnosis to any hospital within 30 days